C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company offers its products through wholesale and retail channels. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does C21 Investments Inc (CXXI) operate in?
C21 Investments Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is C21 Investments Inc (CXXI) current stock price?
As of the latest data, C21 Investments Inc stock price is CA$0.38, with a previous close of CA$0.39. C21 Investments Inc lost -CA$0.01 in the last trading session, representing a -2.56% loss.
What is C21 Investments Inc (CXXI) current market capitalization?
C21 Investments Inc market cap is approximately 45.10 million.
What is C21 Investments Inc (CXXI) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.04.
Does C21 Investments Inc (CXXI) pay dividends?
No. C21 Investments Inc does not pay a dividend.
When is C21 Investments Inc (CXXI) next earnings report?
C21 Investments Inc is expected to release its next earnings report on April 30, 2026.
What is C21 Investments Inc (CXXI) beta (volatility) score?
C21 Investments Inc has a beta of 1.877, suggesting it is more volatile than the market.
